What You Should Know:
– Ezra, a innovator in AI-driven cancer screening, today announced that its advanced Ezra Flash AI model has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
– The FDA…
Continue Reading
Food and Drug Administration (FDA) staffers reviewing Elon Musk’s Neuralink were among those fired as part of widespread layoffs within the Agency.Musk is in charge of the new Department of Government Efficiency (DOGE), which…
Continue Reading
Proposed legislation introduced in the U.S. House of Representatives will allow AI and machine learning technology to prescribe drugs approved by the FDA autonomously. The bill, H.R.238, introduced on Jan. 7, would require amending the…
Continue Reading
Sujay Jadhav, Verana Health CEO
In recent years, regulatory bodies, such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have increasingly emphasized the use of real-world data (RWD) in clinical…
Continue Reading
Critical Security Vulnerabilities Discovered
The U.S. Food and Drug Administration has raised serious concerns about cybersecurity vulnerabilities affecting patient monitors manufactured by Chinese company Contec Medical Systems. These security flaws potentially enable cybercriminals to bypass…
Welcome to the January edition of Digital Health Digest, your trusted source for the latest in digital health and healthcare technology!In this episode, we cover major updates transforming the digital health landscape—from Bicycle Health…
Continue Reading
What You Should Know:
– GE HealthCare has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its updated portfolio of Voluson™ Expert Series ultrasound systems.
– The Voluson Expert 22, 20,…
Continue Reading
Hong Kong-based startup PanopticAI has obtained regulatory approval in the United States for its contactless pulse rate measuring application. It received the US Food and Drug Administration’s 510(k) clearance for the PanopticAI Vital Signs app…
Continue Reading
Breaking News: FDA’s Landmark Decision
The Food and Drug Administration (FDA) made a groundbreaking announcement on January 15, 2025, revoking the authorization of Red No. 3 in food products and ingested medications. This decisive action…
Groundbreaking AI Healthcare Regulations Unveiled
The U.S. Food and Drug Administration (FDA) has initiated a transformative step in healthcare technology by releasing comprehensive draft guidance for AI-enabled medical devices on January 6, 2025. This pioneering…
